R&D investor study finds benchmarking, not multi-dimensional portfolios, a key factor in market value
A study of corporate R&D investors has found that while some companies place significant value on IP portfolios that include a combination of rights, markets grant higher premiums to those that are more innovative than their competitors.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the WTR experts.